We are live on ! Find out more
IP

Intellectus Partners Portfolio holdings

AUM $578M
1-Year Est. Return 49.48%
This Fund
S&P 500
This Quarter Est. Return
+6.91%
1 Year Est. Return
+49.48%
3 Year Est. Return
+157.34%
5 Year Est. Return
+153.66%
10 Year Est. Return
–
AUM
$391M
AUM Growth
+$24.9M
Cap. Flow
+$6.5M
Cap. Flow %
1.66%
Top 10 Hldgs %
24.49%
Holding
285
New
24
Increased
110
Reduced
87
Closed
16
Avg Time Held Equity + Options
14 quarters
Top 10 Avg Time Held Equity + Options
10.8 quarters
Top 20 Avg Time Held Equity + Options
12.8 quarters
Avg Time Held Equity only
14 quarters
Top 10 Avg Time Held Equity only
10.8 quarters
Top 20 Avg Time Held Equity only
12.8 quarters

Top Sells

Rank Stock Value
1
KLAC icon
KLA
KLAC
+$3.14M
2
META icon
Meta Platforms (Facebook)
META
+$1.99M
3
NVDA icon
NVIDIA
NVDA
+$1.87M
4
AMZN icon
Amazon
AMZN
+$1.54M
5
GILD icon
Gilead Sciences
GILD
+$1.47M

Sector Composition

Rank Sector Weight
1 Miscellaneous 21.37%
2 Technology 20.82%
3 Consumer Discretionary 13.26%
4 Financials 10.08%
5 Communication Services 9.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
RSP icon
51
Invesco S&P 500 Equal Weight ETF
RSP
$97.4B
$2.07M 0.53%
11,545
+3,073
+36% +$525K
2020 Q4
15 quarters
AXP icon
52
American Express
AXP
$209B
$2.05M 0.52%
7,560
-136
-2% -$33.9K
2022 Q1
10 quarters
BAC icon
53
Bank of America
BAC
$377B
$2.04M 0.52%
51,401
+7,182
+16% +$288K
2016 Q4
31 quarters
HON icon
54
Honeywell
HON
$65.7B
$2.02M 0.52%
10,372
+608
+6% +$118K
2016 Q4
31 quarters
ILMN icon
55
Illumina
ILMN
$40.9B
$2.01M 0.51%
15,440
+1,935
+14% +$239K
2016 Q4
31 quarters
IBB icon
56
iShares Biotechnology ETF
IBB
$10.2B
$2M 0.51%
13,705
-1,051
-7% -$152K
2019 Q1
22 quarters
GBIL icon
57
Goldman Sachs Access Treasury 0-1 Year ETF
GBIL
$7.9B
$1.95M 0.5%
19,463
+16,013
+464% +$1.6M
2024 Q1
2 quarters
BCX icon
58
BlackRock Resources & Commodities Strategy Trust
BCX
$941M
$1.9M 0.49%
197,839
-7,323
-4% -$67.4K
2021 Q2
13 quarters
SLV icon
59
iShares Silver Trust
SLV
$28.8B
$1.82M 0.47%
64,156
-5,200
-7% -$140K
2020 Q2
17 quarters
ORCL icon
60
Oracle
ORCL
$434B
$1.81M 0.46%
10,632
+4,947
+87% +$717K
2016 Q4
31 quarters
CSCO icon
61
Cisco
CSCO
$454B
$1.81M 0.46%
33,927
-5,117
-13% -$249K
2016 Q4
31 quarters
GILD icon
62
Gilead Sciences
GILD
$183B
$1.8M 0.46%
21,429
-19,330
-47% -$1.47M
2016 Q4
31 quarters
ABNB icon
63
Airbnb
ABNB
$97.6B
$1.77M 0.45%
13,930
+125
+0.9% +$16.2K
2021 Q3
12 quarters
FSK icon
64
FS KKR Capital
FSK
$2.96B
$1.76M 0.45%
87,434
+44,546
+104% +$885K
2023 Q4
3 quarters
BIDU icon
65
Baidu
BIDU
$28.5B
$1.74M 0.45%
16,538
+250
+2% +$22.1K
2017 Q2
29 quarters
ET icon
66
Energy Transfer Partners
ET
$70.5B
$1.72M 0.44%
107,322
+92
+0.1% +$1.48K
2022 Q2
9 quarters
WMT icon
67
Walmart Inc
WMT
$891B
$1.71M 0.44%
21,146
-1,842
-8% -$135K
2016 Q4
31 quarters
ARCC icon
68
Ares Capital
ARCC
$13.3B
$1.7M 0.44%
81,386
+30,696
+61% +$638K
2023 Q3
4 quarters
TTE icon
69
TotalEnergies
TTE
$196B
$1.66M 0.42%
25,370
+1,500
+6% +$102K
2022 Q2
9 quarters
PEP icon
70
PepsiCo
PEP
$173B
$1.65M 0.42%
9,722
+1,843
+23% +$317K
2020 Q1
18 quarters
WDAY icon
71
Workday
WDAY
$44.8B
$1.61M 0.41%
6,596
+104
+2% +$24.6K
2019 Q4
19 quarters
ETHE icon
72
Grayscale Ethereum Staking ETF Shares
ETHE
$1.9B
$1.58M 0.4%
+72,025
New +$1.62M
2024 Q3
0 quarters
IWM icon
73
iShares Russell 2000 ETF
IWM
$77.9B
$1.56M 0.4%
7,079
-2,589
-27% -$554K
2019 Q1
22 quarters
BMY icon
74
Bristol-Myers Squibb
BMY
$116B
$1.55M 0.4%
29,992
-1,343
-4% -$63K
2016 Q4
31 quarters
USMV icon
75
iShares MSCI USA Min Vol Factor ETF
USMV
$23.8B
$1.54M 0.39%
16,823
+98
+0.6% +$8.64K
2019 Q1
22 quarters

Similar funds

Intellectus Partners's Q3 2024 Portfolio in Review

As of Q3 2024, Intellectus Partners held 285 positions worth $391M, up 6.8% from $366M the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Intellectus Partners's Q3 2024 filing shows 24 new, 110 increased, 87 reduced and 16 closed positions. Its largest new stake was Corcept Therapeutics: 54,859 shares worth $2.54M. The largest sale was KLA, an estimated $3.14M.

By sector, the portfolio is most concentrated in Miscellaneous at 21% of assets, up from 20% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Intellectus Partners's largest Q3 2024 buy was Corcept Therapeutics: 54,859 shares worth $2.54M.
  • Intellectus Partners added most to Snowflake in Q3 2024, an estimated $1.78M increase.
  • Intellectus Partners's biggest Q3 2024 reduction was KLA, cutting an estimated $3.14M.
  • Intellectus Partners fully exited Biogen in Q3 2024, selling an estimated $1.4M.
  • Intellectus Partners's ten largest holdings make up 24% of its $391M portfolio in Q3 2024.
  • Intellectus Partners opened 24 new positions and closed 16 in Q3 2024.
  • Intellectus Partners's portfolio value rose 6.8% quarter-over-quarter to $391M.

Based on Intellectus Partners's 13F filing for Q3 2024, filed 6 Nov 2024.